PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.
Also called NCT06630923
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 250 participants
- Registry
-
NCT06630923
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Greece
- Registry status
- Recruiting
Technical summary
Registry record NCT06630923. Randomized; no masking; primary purpose prevention. Start 2023-01-14 (actual); primary completion 2025-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS
- Condition
- Diuretics Drug Reactions
- Condition
- Heart Failure; With Decompensation
- Condition
- Albumin; Double
- Intervention (Drug)
- Human albumin
- Lead sponsor
- Democritus University of Thrace
Record details
- Record id
cardio:ct-nct06630923- Content hash
6126e4e6bcec67112859b3a212dc323acd01335f5807a74d5e1848985c836825